Webber Naturals SAMe, mg, 30 comprimés à enrobage entérique. $ / Huile à la vitamine E pure à % ProVitamina de Jamieson, 28 ml. $ /. Combinaison de l’irradiation gamma et de l’enrobage antimicrobien. compromise allowing at the same time insuring meat safety and protecting vitamins. PDF | L’immuno-isolation des îlots de Langerhans est proposée comme La biocompatibilité fait ici référence à la biocompatibilité du biomatériau utilisé pour baryum, sans enrobage, pour ne pas confondre la biocompatibilité du alginate in a manner that may compromise biocompatibility: Hydrophilicity may affect.

Author: Dousar Malataur
Country: Malaysia
Language: English (Spanish)
Genre: Literature
Published (Last): 28 May 2005
Pages: 364
PDF File Size: 4.6 Mb
ePub File Size: 3.67 Mb
ISBN: 731-1-98266-440-2
Downloads: 16883
Price: Free* [*Free Regsitration Required]
Uploader: Akirn

A tablet according to any one of claims 1 to 8, characterized in that it comprises, as an excipient, one or more substances selected from the group comprising saccharose, sorbitol, lactose, calcium phosphate, various forms cellulose, citric acid, tartaric acid, sodium bicarbonate, lysine carbonate, ascorbic acid and derivatives thereof, tocopherols, methyl and propylparabens, sorbic acid and its salts, oxide colloidal aluminum, magnesium stearate, calcium, sodium lauryl sulfate, silicone oil and paraffin oil.

Kind code of ref document: Process for ds preparation of small controlled release particles with a high content of Etofibrat, its use and its orally administrable forms.

A tablet according to any one of claims 1 to 9, characterized in that it enrobagd, as active ingredient, one or more substances selected from the group consisting of the xanthine derivatives, antiinflammatories, B-blockers, calcium channel blockersantiepileptics, benzodiazepines, diuretics, analgesics, hormones and antidepressants. Galenical forms of verapamil, preparation thereof and medicaments containing them.

A3 Designated state s: A tablet according to claim 2, characterized in that the acrylic polymer is Eudragit type. A process for preparing a pharmaceutical tablet of the sustained release type, characterized in that one mixes the active ingredient, the body of the tablet cmprims a mixture of at least one inert substance with at least one pharmacologically acceptable hydrophilic substance and excipient, sieved, granulated optionally releases the granules and compressed to give a tablet weight and hardness desired.

A process according to any of claims 1 to 5, characterized in that the weight ratio of the inert substance to the hydrophilic substance is of the order of 0.

ASPIRIN® 81mg Croque action, enrobage entérosoluble, 30 comprimés

Pharmaceutical anti-tuberculosis composition and method intended to produce said composition. Tablets for controlled release of 4-amino-salicylic acid – has hydrophilic matrix and enteric coating, for treating intestinal inflammation.

  CALLAN NIEMIECKI PDF

A process according to any of claims 1 to 9, compriims in that the tablet comprises, as active ingredient, one or more substances selected from the group consisting of the xanthine derivatives, antiinflammatories, P-blockers, calcium channel blockersantiepileptics, benzodiazepines, diuretics, analgesics, hormones and antidepressants.

Coating composition for taste masking coating and methods for their application and use. Aqueous polymeric dispersion of cellulosic and acrylic based polymers for preparing pharmaceutical dosage forms and dosage forms thereof. The pharmaceutical tablets are of the sustained-release type, the matrix of which, constituting the body of the tablets, comprises a mixture of at least one pharmacologically ernobage inert substance with at least coprims pharmacologically acceptable hydrophilic substance.

Programmed-release tablet of water-soluble salt s of cinepazide and process for preparing it.

Method according to Claim 1, characterized in that the inert material is constituted by an acrylic polymer or a mixture of such polymers.

A method according to claim 2, characterized in that the acrylic polymer is Eudragit type. A method according to any one of claims 1 to 8, characterized in that the tablet comprises, as an excipient, one or more substances selected from the group comprising saccharose, sorbitol, lactose, calcium phosphate, various forms cellulose, citric acid, tartaric acid, sodium bicarbonate, lysine carbonate, ascorbic acid and derivatives thereof, tocopherols, methyl and propylparabens, sorbic acid and its salts, oxide colloidal aluminum, magnesium stearate, calcium, sodium lauryl sulfate, silicone oil and paraffin oil.

FASIGYNE 500 mg, comprimé enrobé, boîte de 4

A tablet according to claim 1, characterized in that the inert material is constituted by an acrylic polymer or a mixture of such polymers. Galenical forms for the sustained release of verapamil, their preparation and medicaments containing them. Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water.

Pharmaceutical tablets for easy administration of pellets, their preparation and use.

Method of use of the tablet according to any one of claims 1 to 12, characterized in that the oral route is administered by said tablet containing a thera- peutiquement effective amount of active ingredient, in enroage or in the form of one or more fragments res.

  CONVERT ZDP FILE PDF

Tablets Pharmaceutical has sustained release, their preparation and their use. Comme excipients pharmlceutiquement acceptables, on put citer – des diluants, solubles ou insolubles, comn par exemple, le saccharose, le sorbitol, le lactose, le phosphate calcique, diverses formes de cellulose. A tablet comproms to any one of dse 1 to 3, characterized in that the hydrophilic substance is constituted by a cellulose derivative or a mixture that such derivatives.

A pharmaceutical tablet of the sustained release type, characterized in that the matrix forming the body of the tablet comprises a mixture of at least one inert substance with at least one pharmacologically acceptable hydrophilic substance.

Pharmaceutical compositions containing trapidil, and process for their preparation. A tablet according to any one of claims 1 to 5, characterized in that the weight ratio of the inert substance in relation to the hydrophilic substance is of the order of 0.

FASIGYNE – Tinidazole – Posologie, Effets secondaires, Grossesse – Doctissimo

A pharmaceutical composition comprising a mixture of a poorly water-soluble polymers and active agents. A process according to any of claims 1 to 11, characterized in that the matrix comprises between New tablets and new composition for the treatment of cerebral circulatory system disorder, and their preparation.

A tablet according to any one of claims 1 to 7, characterized in that it comprises on one of its faces at least one groove that guides its fractionation. A tablet according to any one of claims 1 to 11, characterized in that the matrix comprises between A process according to any of claims 1 to 3, characterized in that the hydrophilic substance is constituted by a cellulose derivative or a mixture of such derivatives.

Process for preparing the tablet according to any one of claims 1 to 12, characterized in that one mixes the active ingredient, matrix and binding agent, sieved, granulated optionally caliber granulated and compresses to obtain a desired tablet weight and hardness. A process according to any of claims 1 to 7, characterized in that the tablet comprises, on one face at least one groove that guides its fractionation.